The COVID-19 Antigen Rapid Test is a lateral flow immunoassay based on the principle of double antibody sandwich technology. The SARS-CoV-2 nucleocapsid protein monoclonal antibody conjugated with colored microparticles is used as a detector and sprayed onto the conjugation pad. During the test, the SARS-CoV-2 antigen in the sample interacts with the SARS-CoV-2 antibody, which is conjugated with colored microparticles, creating an antigen-antibody-labeled complex. This complex migrates via capillary action on the membrane to the
test line, where it is captured by the pre-coated monoclonal SARS-CoV-2 nucleocapsid protein antibody. A colored test line (T) would be visible in the result window if SARS-CoV-2 antigens are present in the sample. The absence of the T-line indicates a negative result. The control line (C) is used as a procedural control and should always be displayed when the test procedure is being carried out properly.
 

• CE certified (CE 1434)
• Sensitivity: 94,5 %
• Specificity: 99,9 %
•  Clear result after less than 10 minutes
• Simple and painless application
•  Fast test result
• CE certified and therefore approved throughout Europe CE 1434)
• BfArM listed
• evaluated by the Paul Ehrlich Institute
•  reacts to the Omikron mutant
• very high reliability
• Recognizes a variety of mutations (Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Epsilon (B.1.427 / B.1.429), Delta (B.1.617.2))

Set consisting of

• 1 test cassette
• 1 Sterile swab
• 1 extraction tube
• 1 extraction buffer
• 1 instruction leaflet
• 1 qualification certificate
• 1 workstation
• 1 biowaste bag

White Listed in:

• Germany
• France
• Belgium
• Austria
• Czech Republic
• Slovakia
• Slovenia
• Bulgaria
• Malaysia
• Chile
• Ecuador
• Lithuania
• Thailand
• Poland